Cargando…
Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes
Many patients with bone marrow failure syndromes need frequent transfusions of red blood cells, and most of them eventually suffer from organ dysfunction induced by excessively accumulated iron. The only way to treat transfusion-induced iron overload is iron chelating therapy. However, most patients...
Autores principales: | Suzuki, Takahiro, Tomonaga, Masao, Miyazaki, Yasushi, Nakao, Shinji, Ohyashiki, Kazuma, Matsumura, Itaru, Kohgo, Yutaka, Niitsu, Yoshiro, Kojima, Seiji, Ozawa, Keiya |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2516546/ https://www.ncbi.nlm.nih.gov/pubmed/18581199 http://dx.doi.org/10.1007/s12185-008-0119-y |
Ejemplares similares
-
Body iron metabolism and pathophysiology of iron overload
por: Kohgo, Yutaka, et al.
Publicado: (2008) -
Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
por: Gattermann, Norbert
Publicado: (2008) -
Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea
por: Lee, Jong Wook
Publicado: (2008) -
Diversity of disseminated intravascular coagulation and selection of appropriate treatments
por: Asakura, Hidesaku
Publicado: (2020) -
COVID-19-associated coagulopathy and disseminated intravascular coagulation
por: Asakura, Hidesaku, et al.
Publicado: (2020)